Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 443

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 443
---
ED, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2024

(Audited)

Note 1 – Nature of Business and Significant
Accounting Policies

Nature of Business

WEED, Inc. (the “Company”), (formerly
United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (“Inception Date”) as Plae,
Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines,
Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade “Cultivation
Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with
a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company
providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was
formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed
on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on
the OTC Pink Sheets under the stock symbol: BUDZ.

On April 20, 2017, the Company acquired Sangre AT,
LLC, a Wyoming company doing business as Sangre AgroTech. (“Sangre”). Sangre is a plant genomic research and breeding company
comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and
plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available.
No work is being conducted now until further funds are available.

On May 2, 2022, the Company acquired Hempirical Genetics,
LLC, a Arizona company.

The accompanying financial statements have been prepared
in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments,
consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information
contained therein.

The Company has a calendar year end for reporting
purposes.

Basis of Presentation:

The